H
Harvest
Tax-loss replacement research
RGEN
Repligen
Health Care›Biotechnology›Biotechnology
28 stocks · 12 ETFs
data as of Oct 2, 2026
REPLACEMENT RESEARCH

Tax-loss harvesting alternatives for RGEN

Among the 28 Biotechnology peers screened, FTRE (Fortrea) has tracked RGEN most closely over the past year, with a return correlation of 0.48. The strongest fund stand-in is ARKG (ARK Genomic Revolution ETF) at 0.56 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →
STOCKS

Single-name peers

TickerNameSub-industry1Y3Y5Y10Y
FTREFortreaBiotechnology0.480.360.34—
VCELVericelBiotechnology0.370.320.380.31
INCYIncyteBiotechnology0.290.220.250.29
LGNDLigand Pharmaceuticals, Inc.Biotechnology0.250.290.300.33
KRYSKrystal BiotechBiotechnology0.240.230.210.23
BMRNBioMarin PharmaceuticalBiotechnology0.240.270.310.33
HALOHalozymeBiotechnology0.240.240.260.31
VRTXVertex PharmaceuticalsBiotechnology0.230.220.220.30
MRNAModerna Inc.Biotechnology0.220.220.270.23
EXELExelixisBiotechnology0.210.150.210.26
ADMAADMA Biologics, Inc.Biotechnology0.210.230.260.19
CYTKCytokineticsBiotechnology0.210.180.230.24
AMGNAmgen Inc.Biotechnology0.200.220.190.26
SRPTSarepta TherapeuticsBiotechnology0.190.180.210.23
ROIVRoivant SciencesBiotechnology0.190.260.23—
ALNYAlnylam PharmaceuticalsBiotechnology0.180.170.210.26
GILDGilead SciencesBiotechnology0.170.140.160.22
TGTXTG Therapeutics, Inc.Biotechnology0.170.190.260.26
XNCRXencor IncBiotechnology0.160.270.290.32
VIRVir Biotechnology, Inc.Biotechnology0.160.250.290.19
BIIBBiogen Inc.Biotechnology0.160.260.250.23
NBIXNeurocrine BiosciencesBiotechnology0.150.230.240.28
ARWRArrowhead PharmaceuticalsBiotechnology0.150.310.360.30
RCUSArcus Biosciences, Inc.Biotechnology0.150.240.270.27
HRMYHarmony Biosciences Holdings, Inc.Biotechnology0.130.190.230.20
REGNRegeneron PharmaceuticalsBiotechnology0.120.240.260.30
PTGXProtagonist Therapeutics, Inc.Biotechnology0.070.070.130.12
UTHRUnited TherapeuticsBiotechnology-0.000.090.100.19
ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

TickerNameFocusMatch1Y3Y5Y10Y
ARKGARK Genomic Revolution ETFGenomics (Active)INDUSTRY0.560.530.570.56
IBBiShares Biotechnology ETFBiotechnologyINDUSTRY0.440.510.570.56
FHLCFidelity MSCI Health Care ETFHealth Care SectorSECTOR0.420.460.500.51
VHTVanguard Health Care ETFHealth Care SectorSECTOR0.420.460.510.51
IYHiShares US Healthcare ETFHealth Care SectorSECTOR0.400.440.480.49
IHIiShares Medical Devices ETFMedical DevicesSUB-IND0.380.410.500.51
XLVHealth Care Select Sector SPDRHealth Care SectorSECTOR0.370.420.450.46
XBISPDR S&P Biotech ETFBiotechnology (Equal Wt)INDUSTRY0.360.450.490.51
XPHSPDR S&P PharmaceuticalsPharmaceuticals (Equal Wt)INDUSTRY0.350.430.480.48
IHEiShares US Pharmaceuticals ETFPharmaceuticalsINDUSTRY0.290.340.380.44
PPHVanEck Pharma ETFPharmaceuticalsINDUSTRY0.270.300.340.39
IHFiShares Health Care ProvidersHealth Care ProvidersINDUSTRY0.170.230.300.33
NEXT STEPS

Harvesting a loss in RGEN?

RELATED

Replacement research for RGEN's peers

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.